View:
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
July 15, 2002
- ------------------
(Date of earliest event reported)
LABORATORY CORPORATION OF AMERICA HOLDINGS
- ------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 1-11353 13-3757370
-------------- ----------- --------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification
incorporation) Number)
358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA 27215
- -------------------------------------------------------
(Address of principal executive offices)
336-229-1127
- ------------
(Registrant's telephone number, including area code)
ITEM 5. OTHER EVENTS
Laboratory Corporation of America -Registered Trademark-Holdings
(LabCorp -Registered Trademark-)(NYSE:LH) announced that it has signed
a national contract with San Diego-based Premier, Inc., one of the
country's largest group purchasing organizations. LabCorp's nationwide
network of clinical reference laboratories now offers more than 4,000
diagnostic tests to member hospitals in the Premier network.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL
INFORMATION AND EXHIBITS
(c) Exhibit
20 Press release of the Company dated July 15, 2002.
SIGNATURES
Pursuant to the requirements of the Securities and
Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the
undersigned hereunto duly authorized.
LABORATORY CORPORATION OF AMERICA HOLDINGS
------------------------------------------
(Registrant)
By:/s/ BRADFORD T. SMITH
--------------------------------
Bradford T. Smith
Executive Vice President
and Secretary
Date: July 15, 2002
Laboratory Corporation of America-Registered Trademark- Holdings
358 South Main Street
Burlington, NC 27215
Telephone: 336-584-5171
FOR IMMEDIATE RELEASE
Contact: 336-436-4855
Pamela Sherry
Shareholder Direct: 800-LAB-0401
www.labcorp.com
LABORATORY CORPORATION OF AMERICA-REGISTERED TRADEMARK- SIGNS
GROUP PURCHASING AGREEMENT WITH PREMIER
Burlington, NC, July 15, 2002 - Laboratory Corporation of America-Registered
Trademark- Holdings (LabCorp-Registered Trademark-) (NYSE: LH) today announced
that it has signed a national contract with San Diego-based Premier, Inc., one
of the country's largest group purchasing organizations. LabCorp's nationwide
network of clinical reference laboratories now offers more than 4,000
diagnostic tests to member hospitals in the Premier network.
"We are pleased with this significant new business opportunity to offer our
full range of laboratory services to this extensive organization of health
care providers," noted Stevan R. Stark, executive vice president of marketing
and sales for LabCorp. "Our national presence and leading-edge testing
technology, coupled with our capability to offer direct electronic
connectivity to streamline ordering and result delivery, favorably position
LabCorp to meet the testing and information needs of Premier's hospital
members."
Premier is an alliance comprising 1,600 not-for-profit hospitals committed to
improving healthcare quality, enhancing safety and reducing costs. The
group's contracts provide for hospitals to purchase products at cost-effective
pricing and terms.
The first national clinical laboratory to fully embrace genomic testing,
Laboratory Corporation of America-Registered Trademark- Holdings (LabCorp-
Registered Trademark-) has been a pioneer in commercializing new diagnostic
technologies. As a national laboratory with annual revenues of $2.2 billion
in 2001 and over 19,000 employees, the company offers more than 4,000 clinical
tests ranging from routine blood analyses to sophisticated molecular
diagnostics. Serving more than 200,000 clients nationwide, LabCorp combines
its expertise in innovative clinical testing technology with its Centers of
Excellence. The Center for Molecular Biology and Pathology, in Research
Triangle Park, North Carolina, offers state-of-the-art molecular gene-based
testing in infectious disease, oncology and genetics. Its National Genetics
Institute in Los Angeles is an industry leader in developing novel, highly
sensitive polymerase chain reaction (PCR) methods for testing hepatitis C and
other blood borne infectious agents. LabCorp's Minneapolis-based ViroMed
offers molecular microbial testing using real time PCR platforms, while its
Center for Esoteric Testing in Burlington, North Carolina, performs the
largest volume of specialty testing in the network. LabCorp's clients include
physicians, state and federal government, managed care organizations,
hospitals, clinics, pharmaceutical and Fortune 1000 companies, and other
clinical laboratories.
Each of the above forward-looking statements is subject to change based on
various important factors, including without limitation, competitive actions
in the marketplace and adverse actions of governmental and other third-party
payors. Further information on potential factors that could affect LabCorp's
financial results is included in the Company's Form 10-K for the year ended
December 31, 2001 and subsequent SEC filings.